Nine Enzymes Are Required for Assembly of the Pacidamycin Group of Peptidyl Nucleoside Antibiotics

Overview

Journal J Am Chem Soc

Publisher American Chemical Society

Specialty Chemistry

Date 2011 Mar 23

PMID 21417270

Citations 28

Authors

Wenjun Zhang

Ioanna Ntai

Megan L Bolla

Steven J Malcolmson

Daniel Kahne

Neil L Kelleher

Christopher T Walsh

Affiliations

Soon will be listed here.

Abstract

Pacidamycins are a family of uridyl peptide antibiotics that inhibit the translocase MraY, an essential enzyme in bacterial cell wall biosynthesis that to date has not been clinically targeted. The pacidamycin structural skeleton contains a doubly inverted peptidyl chain with a β-peptide and a ureido linkage as well as a 3'-deoxyuridine nucleoside attached to DABA(3) of the peptidyl chain via an enamide linkage. Although the biosynthetic gene cluster for pacidamycins was identified recently, the assembly line of this group of peptidyl nucleoside antibiotics remained poorly understood because of the highly dissociated nature of the encoded nonribosomal peptide synthetase (NRPS) domains and modules. This work has identified a minimum set of enzymes needed for generation of the pacidamycin scaffold from amino acid and nucleoside monomers, highlighting a freestanding thiolation (T) domain (PacH) as a key carrier component in the peptidyl chain assembly as well as a freestanding condensation (C) domain (PacI) catalyzing the release of the assembled peptide by a nucleoside moiety. On the basis of the substrate promiscuity of this enzymatic assembly line, several pacidamycin analogues were produced using in vitro total biosynthesis.

Citing Articles

New insights into the dihydro-mureidomycin biosynthesis controlled by two unusual proteins in Streptomyces roseosporus.

Liu N, Xu Y, Shang F, Sun H, Liu X, Huang Y Microb Cell Fact. 2023; 22(1):255.

PMID: 38087285 PMC: 10714638. DOI: 10.1186/s12934-023-02260-6.

Expanding structural diversity of 5'-aminouridine moiety of sansanmycin via mutational biosynthesis.

Lu Y, Li Y, Fan J, Li X, Sun H, Wang L Front Bioeng Biotechnol. 2023; 11:1278601.

PMID: 38026887 PMC: 10643210. DOI: 10.3389/fbioe.2023.1278601.

Biosynthesis and Genome Mining Potentials of Nucleoside Natural Products.

Du Y, Thanapipatsiri A, Yokoyama K Chembiochem. 2023; 24(17):e202300342.

PMID: 37357819 PMC: 10530009. DOI: 10.1002/cbic.202300342.

Elucidating the molecular programming of a nonlinear non-ribosomal peptide synthetase responsible for fungal siderophore biosynthesis.

Jenner M, Hai Y, Nguyen H, Passmore M, Skyrud W, Kim J Nat Commun. 2023; 14(1):2832.

PMID: 37198174 PMC: 10192304. DOI: 10.1038/s41467-023-38484-8.

The Assembly-Line Enzymology of Nonribosomal Peptide Biosynthesis.

Maruyama C, Hamano Y Methods Mol Biol. 2023; 2670:3-16.

PMID: 37184697 DOI: 10.1007/978-1-0716-3214-7_1.

References

Fronko R, Lee J, Galazzo J, Chamberland S, Malouin F, Lee M . New pacidamycins produced by Streptomyces coeruleorubidus, NRRL 18370. J Antibiot (Tokyo). 2001; 53(12):1405-10. DOI: 10.7164/antibiotics.53.1405. View

Sun D, Jones V, Carson E, Lee R, Scherman M, McNeil M . Solid-phase synthesis and biological evaluation of a uridinyl branched peptide urea library. Bioorg Med Chem Lett. 2007; 17(24):6899-904. PMC: 2140236. DOI: 10.1016/j.bmcl.2007.09.097. View

Boojamra C, Lemoine R, Lee J, Leger R, Stein K, Vernier N . Stereochemical elucidation and total synthesis of dihydropacidamycin D, a semisynthetic pacidamycin. J Am Chem Soc. 2001; 123(5):870-4. DOI: 10.1021/ja003292c. View

Chen R, Buko A, Whittern D, McAlpine J . Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation. J Antibiot (Tokyo). 1989; 42(4):512-20. DOI: 10.7164/antibiotics.42.512. View

Xie Y, Chen R, Si S, Sun C, Xu H . A new nucleosidyl-peptide antibiotic, sansanmycin. J Antibiot (Tokyo). 2007; 60(2):158-61. DOI: 10.1038/ja.2007.16. View

Kaysser L, Tang X, Wemakor E, Sedding K, Hennig S, Siebenberg S . Identification of a napsamycin biosynthesis gene cluster by genome mining. Chembiochem. 2011; 12(3):477-87. DOI: 10.1002/cbic.201000460. View

Strieter E, Vaillancourt F, Walsh C . CmaE: a transferase shuttling aminoacyl groups between carrier protein domains in the coronamic acid biosynthetic pathway. Biochemistry. 2007; 46(25):7549-57. DOI: 10.1021/bi700243h. View

Winn M, Goss R, Kimura K, Bugg T . Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis. Nat Prod Rep. 2010; 27(2):279-304. DOI: 10.1039/b816215h. View

Bunnage M, Burke A, Davies S, Millican N, Nicholson R, Roberts P . Asymmetric synthesis of anti-(2S,3S)- and syn-(2R,3S)-diaminobutanoic acid. Org Biomol Chem. 2003; 1(21):3708-15. DOI: 10.1039/b306936m. View

10.

Isono F, Inukai M, Takahashi S, HANEISHI T, Kinoshita T, Kuwano H . Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. II. Structural elucidation. J Antibiot (Tokyo). 1989; 42(5):667-73. DOI: 10.7164/antibiotics.42.667. View

11.

Zhang W, Ostash B, Walsh C . Identification of the biosynthetic gene cluster for the pacidamycin group of peptidyl nucleoside antibiotics. Proc Natl Acad Sci U S A. 2010; 107(39):16828-33. PMC: 2947877. DOI: 10.1073/pnas.1011557107. View

12.

Rackham E, Gruschow S, Ragab A, Dickens S, Goss R . Pacidamycin biosynthesis: identification and heterologous expression of the first uridyl peptide antibiotic gene cluster. Chembiochem. 2010; 11(12):1700-9. DOI: 10.1002/cbic.201000200. View

13.

Chatterjee S, Nadkarni S, Vijayakumar E, Patel M, Ganguli B, Fehlhaber H . Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82,11372. J Antibiot (Tokyo). 1994; 47(5):595-8. DOI: 10.7164/antibiotics.47.595. View

14.

Boojamra C, Lemoine R, Blais J, Vernier N, Stein K, Magon A . Synthetic dihydropacidamycin antibiotics: a modified spectrum of activity for the pacidamycin class. Bioorg Med Chem Lett. 2003; 13(19):3305-9. DOI: 10.1016/s0960-894x(03)00682-6. View

15.

Winans K, Bertozzi C . An inhibitor of the human UDP-GlcNAc 4-epimerase identified from a uridine-based library: a strategy to inhibit O-linked glycosylation. Chem Biol. 2002; 9(1):113-29. DOI: 10.1016/s1074-5521(02)00093-5. View